However, there was no significant difference in serum sPD-L1 level between NSCLC patients and healthy subjects, and there was no correlation between serum sPD-L1 level and other clinicopathological features except tumor size (> 2.5 cm) (P> 0.05). This evidence concerns the gene SPDL1 and non-small cell lung carcinoma.